Genmab A/S (GMAB) Stock Price

32.30 ▲ +1.06 (+3.39%)
Open: 31.675 Vol: 2.08M Day's range: 31.62 - 32.51 Dec 11, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
GMAB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 32.30▼ 32.31▼ 32.33▼ 31.63▲ 31.42▲
MA10 32.29▲ 32.31▼ 31.97▲ 31.73▲ 30.92▲
MA20 32.31▼ 31.88▲ 31.55▲ 31.19▲ 28.58▲
MA50 32.33▼ 31.60▲ 31.73▲ 30.89▲ 24.01▲
MA100 32.03▲ 31.72▲ 31.48▲ 28.16▲ 25.20▲
MA200 31.57▲ 31.40▲ 30.53▲ 24.47▲ 30.79▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▲ 0.031▲ 0.133▲ 0.016▲ 0.113▲
RSI 46.825▼ 67.493▲ 66.373▲ 61.001▲ 64.354▲
STOCH 67.234     60.611     91.026▲ 52.502     54.310    
WILL %R -42.105     -15.748▲ -12.121▲ -9.052▲ -20.737▲
CCI 51.025     34.774     68.834     98.057     67.007    
Latest Filters Detected On GMAB
▲ PSAR&MOM $GMAB PSAR Switch Up + Momentum Set Alert
▲ RSI&MACD $GMAB MACD cross and RSI above 55 Set Alert
▲ MACD $GMAB MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $GMAB Price Crossed Above MA(13) Set Alert
MA $GMAB Price Crossed Above MA(7) Set Alert
Genmab A/S News
Dow Jones futures: Broadcom sees AI chip sales doubling, but the stock is tumbling
Thursday, December 11, 2025 03:43 PM
The Dow Jones and Russell 2000 hit record highs while the Nasdaq slashed early losses. Broadcom sees AI chip sales doubling.
Genmab to Hold 2025 R&D Update and ASH Data Review Meeting
Wednesday, December 10, 2025 11:04 PM
Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; HexaBody®; DuoHexaBody®, ...
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2 ...
Sunday, December 07, 2025 05:03 AM
Media ReleaseCOPENHAGEN, Denmark; December 7, 2025 Trial demonstrated treatment with fixed duration EPKINLY plus rituximab and lenalidomide (EPKINLY+ R2) resulted in statistically significant and ...
GMAB historical stock data
date open high low close volume
11/12/25 31.675 32.51 31.62 32.30 2,078,466
10/12/25 31.01 31.4065 30.81 31.24 1,684,221
09/12/25 31.34 31.58 30.93 30.93 1,047,299
08/12/25 32.02 32.1706 31.685 31.94 1,482,640
05/12/25 32.06 32.1299 31.50 31.74 781,657
04/12/25 32.04 32.41 31.63 32.02 1,235,976
03/12/25 31.63 31.75 31.41 31.68 1,050,316
02/12/25 31.58 31.815 31.32 31.71 1,521,354
01/12/25 32.40 32.47 31.315 31.39 1,418,988
28/11/25 31.68 32.48 31.46 32.36 2,352,134
Quote Details
52wk Low:17.235
52wk High:33.65
Vol:2.08M
Avg Vol(3m):36.1M
1Y Chng:+53.66%
1M Chng:+12.66%
Add to Watch List
More Information
Index US Composite
Market Cap. 19.37B